| Identification | Back Directory | [Name]
NCX 116 | [CAS]
860005-21-6 | [Synonyms]
NCX 116
PF-3187207
Latanoprostene bunod
(Z)-4-(nitrooxy)butyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R)-3-hydroxy-5-phenylpentyl)cyclopentyl)hept-5-enoate
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenoic acid 4-(nitrooxy)butyl ester
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-, 4-(nitrooxy)butyl ester, (5Z)- | [Molecular Formula]
C27H41NO8 | [MDL Number]
MFCD30532608 | [MOL File]
860005-21-6.mol | [Molecular Weight]
507.62 |
| Chemical Properties | Back Directory | [Boiling point ]
658.3±55.0 °C(Predicted) | [density ]
1.178±0.06 g/cm3(Predicted) | [storage temp. ]
Hygroscopic, -86°C Freezer, Under inert atmosphere | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Oil | [pka]
14.84±0.70(Predicted) | [color ]
Colourless to Light Yellow | [Stability:]
Hygroscopic, Temperature Sensitive |
| Hazard Information | Back Directory | [Uses]
Latanoprostene Bunod is a derivative of Latanoprost and is used in the treatment of interocular pressure. | [Definition]
ChEBI: Latanoprostene bunod is a prostanoid. |
|
| Company Name: |
Aptus Therapeutics
|
| Tel: |
+91-9966349855 +91-9966349855 |
| Website: |
www.aptustherapeutics.in |
|